SGLT2 Inhibitors Begin to Show Potential in Rheumatology SGLT2 Inhibitors Begin to Show Potential in Rheumatology
Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions.MDedge News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 8, 2024 Category: Endocrinology Tags: Rheumatology Source Type: news
Wegovy, Ozempic Not Linked to Increase in Suicidal Thoughts, US Study Finds Wegovy, Ozempic Not Linked to Increase in Suicidal Thoughts, US Study Finds
A large U.S. study found no evidence that taking Novo Nordisk ' s Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 5, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Lilly Launches Website, Home Delivery Option for Weight-loss Drug Lilly Launches Website, Home Delivery Option for Weight-loss Drug
Eli Lilly and Co on Thursday launched a website to enable people to directly order from the drugmaker including its weight-loss medicine Zepbound as well as connect people...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 4, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Wegovy Maker Novo Nordisk Enters Research Tie-ups With US Biotech Firms Wegovy Maker Novo Nordisk Enters Research Tie-ups With US Biotech Firms
Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big pharma ' s...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 4, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Extreme Heat and Hypoglycemia Risk in Older Insulin Users Extreme Heat and Hypoglycemia Risk in Older Insulin Users
In a large study on older adults with diabetes on insulin in the United States and Taiwan, exposure to higher heat and humidity was associated with an increased risk for serious hypoglycemic events.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 2, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Weight-loss Drugs: Who, and What, Are They Good For? Weight-loss Drugs: Who, and What, Are They Good For?
Powerful weight-loss medicines like Novo Nordisk ' s Wegovy leapt into public view in 2023, from social media to doctors ' offices and cocktail parties, offering a new way to...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 2, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Explainer-What Other Health Conditions Might Weight-loss Drugs Treat? Explainer-What Other Health Conditions Might Weight-loss Drugs Treat?
Novo Nordisk ' s blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 2, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Light Activity in Childhood May Lower Cholesterol Light Activity in Childhood May Lower Cholesterol
Light physical activity may be a crucial intervention target to attenuate the risk for elevated lipid levels and their sequelae in the pediatric population, study said.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 29, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Sustained Weight Loss Linked to Lower Renal Risk in Diabetes Sustained Weight Loss Linked to Lower Renal Risk in Diabetes
Researchers report an independent inverse link between time spent within a target body weight range and composite kidney outcomes in individuals with overweight/obesity and type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 29, 2023 Category: Endocrinology Tags: Nephrology Source Type: news
For Weight Loss With a Low-Carb Diet, Quality Matters For Weight Loss With a Low-Carb Diet, Quality Matters
Only low-carbohydrate diets that emphasized high-quality protein, fat, and carbohydrates from whole grains and other plant-based foods were associated with less weight gain.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 27, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
' Real-time Experiment': Compounded GLP-1s on Coupon Site'Real-time Experiment': Compounded GLP-1s on Coupon Site
Purveyors on coupon sites like Groupon are marketing weight loss programs that include compounded semaglutide and tirzepatide.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 26, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Europe: Erythritol Laxative Effect, Lead Levels Concerning Europe: Erythritol Laxative Effect, Lead Levels Concerning
A new evaluation by the European Food Safety Authority has set a new level for safe consumption of the sweetener while confirming that a warning label will still be necessary.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 22, 2023 Category: Endocrinology Tags: Public Health & Prevention Source Type: news
GLP-1s, Antidiabetic Medications Show Safety in Pregnancy GLP-1s, Antidiabetic Medications Show Safety in Pregnancy
New research shows use of the drugs in pregnancy is on the rise, particularly in the United States, and although teratogenic risks appear low, limitations are notable.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 22, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Many Patients With Type 2 Diabetes Stop Meds After a Year Many Patients With Type 2 Diabetes Stop Meds After a Year
Often, patients with type 2 diabetes on second-line medication discontinue their therapy within a year, warn US researchers who highlight the need for new prescribing approaches.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 21, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
